Lightnews — Scholar-powered news

Kevin Outterson @koutterson.bsky.social · 1d

Issac Weldon from Univ Copenhagen describing what #AMR can learn from environmental governance www.youtube.com/watch?v=f4OS... based on our recent article w Kathleen Liddell (Univ Cambridge) in Milbank: pubmed.ncbi.nlm.nih.gov/40876865/

The Role of Environmental Governance in Tackling AMR

YouTube video by Global Strategy Lab

www.youtube.com

Kevin Outterson @koutterson.bsky.social · 3d

The world needs better science to fight drug-resistant infections. #amr

www.cgdev.org/blog/amr-pan...

The AMR Panel Playbook: Eight Lessons for Building an Independent Panel on Antimicrobial Resistance

Antimicrobial resistance (AMR) is one of the greatest health challenges of our time, responsible for 1.14 million deaths a year. Failure to keep resistance in check could lead to $1.7 trillion dollars...

www.cgdev.org

2 4

Kevin Outterson @koutterson.bsky.social · Sep 10

How should the new Independent Panel on Evidence for Action on #AMR be set up? We gathered scientists and stakeholders - mainly from Africa - to think this through in Lagos, Nigeria. Pre-print now available:

verixiv.org/articles/2-2...

verixiv.org

1 3

Kevin Outterson @koutterson.bsky.social · Sep 8

Another gem: "The widespread prevalence of genomic resistance elements observed, therefore, likely reflects intrinsic resistance elements rather than acquired or emergent resistance mechanisms."

1

Kevin Outterson @koutterson.bsky.social · Sep 8

Who should pay for #AMR innovation?

www.sciencedirect.com/science/arti...
@akesselheim.bsky.social

Bridging the fair share gap for antibacterial innovation: an observational analysis of antibacterial revenues in the G7 and EU27

Antimicrobial resistance (AMR) poses an important global health challenge, including insufficient investment in research and development. This study q…

www.sciencedirect.com

1 2

Kevin Outterson @koutterson.bsky.social · Feb 11

This time with #AMR

Kevin Outterson @koutterson.bsky.social · Feb 11

New funding opportunity opened today for Gram-negative antibacterial discovery (as late as LO) in therapeutics! gcgh.grandchallenges.org/challenge/in...

Innovations for Gram-Negative Antibiotic Discovery

Innovations for Gram-Negative Antibiotic Discovery Grand Challenges RFP

gcgh.grandchallenges.org

1 1

Kevin Outterson @koutterson.bsky.social · Feb 9

Welcome

Marc Mendelson @southafricanasp.bsky.social · Feb 9

Looking forward to a $🚀-free, Orange-free experience on Bluesky 🙂
#AMR #InfectiousDiseases #vaccination #WASH #Pandemics #GlobalHealth #Health

Kevin Outterson @koutterson.bsky.social · Feb 9

Why destroy cancer research and cede global scientific leadership to China?

1

Kevin Outterson @koutterson.bsky.social · Jan 24

It is not clear how Harvard Law Review peer reviews student notes.

Kevin Outterson @koutterson.bsky.social · Jan 24

There might be many good reasons to strengthen such inspections, but is zoonotic transmission in USA a top tier risk that should be prioritized now? I’d like to hear from experts on this.

1

Kevin Outterson @koutterson.bsky.social · Jan 24

This law student note presumes that important zoonotic jumps from animals to humans occur in the USA, leading to a recommendation to more tightly regulate live animal importation. For most salient examples, such as COVID and HIV/AIDS, zoonotic transmission was outside the USA.

Infectious Diseases @infectiousdz.bsky.social · Jan 24

The Harvard Law Review on "The Import of Zoonotic Diseases" in the US.
A timely review as climate and environmental changes, extractive and agricultural industries, and increasing human mobility heighten our risk of exposure to zoonotic infections.
harvardlawreview.org/print/vol-13...

The Import of Zoonotic Diseases

Introduction In 2020, “zoonosis”Zoonoses are “any disease or infection that is naturally transmissible from vertebrate animals to humans.” Zoonoses, WHO (July 29, 2020), https:/

harvardlawreview.org

1 1 3

Kevin Outterson @koutterson.bsky.social · Jan 22

Which lessons can be learned from prior international science panels? How can this help the new Independent Panel on Evidence for Action on AMR? www.cgdev.org/blog/chartin...

Charting the Path to Tackle AMR: How to Create an Inclusive and Impactful Independent Panel

In 2021 alone, AMR killed an estimated 1.14 million people annually—and if countries stick to a business-as-usual approach, it could claim 39 million lives between 2025 and 2050. Beyond the human toll...

www.cgdev.org

2

Kevin Outterson @koutterson.bsky.social · Jan 16

Great morning session on innovation here at this session led by Prof Sam Kariuki, KEMRI

1

Kevin Outterson @koutterson.bsky.social · Jan 16

Now Mingyuan Zhang on the Chinese role in the global antibiotic supply chain, with clever use of antidumping data and trade fairs in her anthropological work.

1

Kevin Outterson @koutterson.bsky.social · Jan 16

Next up was Mirza A Portillo, UC Dublin, on some unintended consequences of antibiotic narratives

1

Kevin Outterson @koutterson.bsky.social · Jan 16

@chddd.bsky.social Univ Vienna, spoke today at the British Academy on his research on the antibiotic pipeline, proposes a new triad of how we could think about success.

1

Kevin Outterson @koutterson.bsky.social · Jan 16

Great morning session on innovation here at this session led by Prof Sam Kariuki, KEMRI

Kevin Outterson @koutterson.bsky.social · Jan 16

Now Mingyuan Zhang on the Chinese role in the global antibiotic supply chain, with clever use of antidumping data and trade fairs in her anthropological work.

1

Kevin Outterson @koutterson.bsky.social · Jan 16

Next up was Mirza A Portillo, UC Dublin, on some unintended consequences of antibiotic narratives

1

Kevin Outterson @koutterson.bsky.social · Jan 16

@chddd.bsky.social Univ Vienna, spoke today at the British Academy on his research on the antibiotic pipeline, proposes a new triad of how we could think about success.

1

Kevin Outterson @koutterson.bsky.social · Jan 15

Dr Sonia Lewycka on equity discourse in AMR. Most AMR deaths are in lower income settings, so solutions must center equity. (Un)intended Consequences conf @ British Academy.

1

Kevin Outterson @koutterson.bsky.social · Jan 9

Nice way to transform Reviewer 2 comments into a paper!

Christian Landry @christianlandry.bsky.social · Jan 9

While writing papers and grants, we received many comments on the role of CNVs in antifungal resistance. We thought we should formally assess how important they are. Here is what we found. #AMR #fungi #evolution rdcu.be/d5rbN

The role of gene copy number variation in antimicrobial resistance in human fungal pathogens

npj Antimicrobials and Resistance - The role of gene copy number variation in antimicrobial resistance in human fungal pathogens

www.nature.com

2 5

Kevin Outterson @koutterson.bsky.social · Dec 24

The most amazingly painful episode of family holidays!

Kevin Outterson @koutterson.bsky.social · Dec 19

I also have concerns about the equities of this system

Jeremy Berg @jeremymberg.bsky.social · Dec 19

My main concerns relate to the question of age of retirement. I have thought about a 5 year rolling contract system whereby a faculty member would have 5 years of job security as long as they were performing at a reasonable level. This addresses the problem of truly non-contributory senior faculty.

1